Screening, Assessment, and Care of Anxiety and Depressive Symptoms in Adults With Cancer

Publication Date: April 13, 2014
Last Updated: March 14, 2022

RECOMMENDATIONS

DEPRESSIVE SYMPTOMS

Screening

All patients should be screened for depressive symptoms at their initial visit, at appropriate intervals, and as clinically indicated, especially with changes in disease or treatment status (ie, post-treatment, recurrence, progression) and transition to palliative and end-of-life care.

○ The Canadian Association of Psychosocial Oncology (CAPO) and the Canadian Partnership Against Cancer (the Partnership) guideline Assessment of Psychosocial Health Care Needs of the Adult Cancer Patient suggests screening at initial diagnosis, start of treatment, regular intervals during treatment, end of treatment, post-treatment or at transition to survivorship, at recurrence or progression, advanced disease, when dying, and during times of personal transition or reappraisal such as family crisis, during post-treatment survivorship and when approaching death.

6731

Overview

Title

Screening, Assessment, and Care of Anxiety and Depressive Symptoms in Adults With Cancer

Authoring Organization